US10543155B2 - Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (VSCs) - Google Patents
Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (VSCs) Download PDFInfo
- Publication number
- US10543155B2 US10543155B2 US14/234,517 US201214234517A US10543155B2 US 10543155 B2 US10543155 B2 US 10543155B2 US 201214234517 A US201214234517 A US 201214234517A US 10543155 B2 US10543155 B2 US 10543155B2
- Authority
- US
- United States
- Prior art keywords
- zinc
- isothiocyanate
- oral
- oral composition
- gum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 150000002540 isothiocyanates Chemical class 0.000 title claims abstract description 58
- 150000003751 zinc Chemical class 0.000 title claims abstract description 52
- 150000003464 sulfur compounds Chemical class 0.000 title claims abstract description 21
- 230000009467 reduction Effects 0.000 title abstract description 21
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 claims description 174
- 235000016720 allyl isothiocyanate Nutrition 0.000 claims description 87
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 47
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims description 43
- 235000015218 chewing gum Nutrition 0.000 claims description 36
- 229940112822 chewing gum Drugs 0.000 claims description 32
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 30
- 239000011576 zinc lactate Substances 0.000 claims description 30
- 235000000193 zinc lactate Nutrition 0.000 claims description 30
- 229940050168 zinc lactate Drugs 0.000 claims description 30
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 claims description 28
- 210000000214 mouth Anatomy 0.000 claims description 21
- QAADZYUXQLUXFX-UHFFFAOYSA-N N-phenylmethylthioformamide Natural products S=CNCC1=CC=CC=C1 QAADZYUXQLUXFX-UHFFFAOYSA-N 0.000 claims description 14
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 12
- 235000009508 confectionery Nutrition 0.000 claims description 12
- 239000011670 zinc gluconate Substances 0.000 claims description 12
- 235000011478 zinc gluconate Nutrition 0.000 claims description 12
- 229960000306 zinc gluconate Drugs 0.000 claims description 12
- IZJDOKYDEWTZSO-UHFFFAOYSA-N phenethyl isothiocyanate Chemical compound S=C=NCCC1=CC=CC=C1 IZJDOKYDEWTZSO-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 16
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 206010006326 Breath odour Diseases 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 14
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000008055 phosphate buffer solution Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 11
- 208000032139 Halitosis Diseases 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 235000003599 food sweetener Nutrition 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 239000003765 sweetening agent Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 8
- HBNYJWAFDZLWRS-UHFFFAOYSA-N ethyl isothiocyanate Chemical compound CCN=C=S HBNYJWAFDZLWRS-UHFFFAOYSA-N 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 235000015487 sulforaphane Nutrition 0.000 description 8
- 229960005559 sulforaphane Drugs 0.000 description 8
- LDKSCZJUIURGMW-UHFFFAOYSA-N 1-isothiocyanato-3-methylsulfanylpropane Chemical compound CSCCCN=C=S LDKSCZJUIURGMW-UHFFFAOYSA-N 0.000 description 7
- -1 Zinc Salts Chemical class 0.000 description 7
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 125000004383 glucosinolate group Chemical group 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- 235000010356 sorbitol Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000001055 chewing effect Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000007937 lozenge Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 6
- 239000011746 zinc citrate Substances 0.000 description 6
- 235000006076 zinc citrate Nutrition 0.000 description 6
- 229940068475 zinc citrate Drugs 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 238000010077 mastication Methods 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 4
- 235000015895 biscuits Nutrition 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 239000008164 mustard oil Substances 0.000 description 4
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 4
- 208000028169 periodontal disease Diseases 0.000 description 4
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000004246 zinc acetate Substances 0.000 description 4
- 235000013904 zinc acetate Nutrition 0.000 description 4
- 240000003291 Armoracia rusticana Species 0.000 description 3
- 235000011330 Armoracia rusticana Nutrition 0.000 description 3
- 241000219198 Brassica Species 0.000 description 3
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 235000014435 Mentha Nutrition 0.000 description 3
- 241001072983 Mentha Species 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008123 high-intensity sweetener Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000018984 mastication Effects 0.000 description 3
- 235000014569 mints Nutrition 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 229940056904 zinc ascorbate Drugs 0.000 description 3
- WWRJFSIRMWUMAE-ZZMNMWMASA-L zinc;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-olate Chemical compound [Zn+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] WWRJFSIRMWUMAE-ZZMNMWMASA-L 0.000 description 3
- NIMLCWCLVJRPFY-UHFFFAOYSA-N 1-(5-bicyclo[2.2.1]hept-2-enyl)ethanone Chemical compound C1C2C(C(=O)C)CC1C=C2 NIMLCWCLVJRPFY-UHFFFAOYSA-N 0.000 description 2
- AYUSDYWETCHGNN-RGOKHQFPSA-N 1-[(1s,3s,4r,5r)-3-isothiocyanato-5-bicyclo[2.2.1]heptanyl]ethanone Chemical compound C1[C@H](N=C=S)[C@H]2[C@H](C(=O)C)C[C@@H]1C2 AYUSDYWETCHGNN-RGOKHQFPSA-N 0.000 description 2
- AYUSDYWETCHGNN-KYXWUPHJSA-N 1-[(1s,3s,4r,5s)-3-isothiocyanato-5-bicyclo[2.2.1]heptanyl]ethanone Chemical compound C1[C@H](N=C=S)[C@H]2[C@@H](C(=O)C)C[C@@H]1C2 AYUSDYWETCHGNN-KYXWUPHJSA-N 0.000 description 2
- BCEFDMYFAAAFPE-UHFFFAOYSA-N 4-(3-isothiocyanatopropyl)morpholine Chemical compound S=C=NCCCN1CCOCC1 BCEFDMYFAAAFPE-UHFFFAOYSA-N 0.000 description 2
- SKIHGKNFJKJXPX-UHFFFAOYSA-N 4-isothiocyanato-1-butene Chemical compound C=CCCN=C=S SKIHGKNFJKJXPX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 2
- 244000221633 Brassica rapa subsp chinensis Species 0.000 description 2
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- 239000004155 Chlorine dioxide Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000019568 aromas Nutrition 0.000 description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-M aspartate(1-) Chemical compound [O-]C(=O)C([NH3+])CC([O-])=O CKLJMWTZIZZHCS-UHFFFAOYSA-M 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000015111 chews Nutrition 0.000 description 2
- 235000019398 chlorine dioxide Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 229940117953 phenylisothiocyanate Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 2
- 229960002218 sodium chlorite Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 125000004354 sulfur functional group Chemical group 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- CKIJIGYDFNXSET-GVGPGJNLSA-N 2-Phenylethylglucosinolate Natural products S(=O)(=O)(O/N=C(/S[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)\CCc1ccccc1)O CKIJIGYDFNXSET-GVGPGJNLSA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 241000219192 Brassica napus subsp. rapifera Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 1
- 240000004073 Brassica oleracea var. viridis Species 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- MREWWWLAQJZJKR-RGDJUOJXSA-N Gluconasturtiin Natural products OC[C@H]1O[C@@H](SC(=NCCc2ccccc2)OS(=O)(=O)O)[C@H](O)[C@@H](O)[C@@H]1O MREWWWLAQJZJKR-RGDJUOJXSA-N 0.000 description 1
- RUQCCAGSFPUGSZ-OBWQKADXSA-N Glucoraphanin Natural products C[S@](=O)CCCCC(=NS(=O)(=O)O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RUQCCAGSFPUGSZ-OBWQKADXSA-N 0.000 description 1
- QQGLQYQXUKHWPX-UHFFFAOYSA-N Glucotropaeolin Natural products OC1C(O)C(O)C(CO)OC1SC(=NOS(O)(=O)=O)CC1=CC=CC=C1 QQGLQYQXUKHWPX-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 244000211187 Lepidium sativum Species 0.000 description 1
- 235000007849 Lepidium sativum Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical group [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 208000026375 Salivary gland disease Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 208000037063 Thinness Diseases 0.000 description 1
- 206010043945 Tongue coated Diseases 0.000 description 1
- 206010063957 Tonsillolith Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 244000195452 Wasabia japonica Species 0.000 description 1
- 235000000760 Wasabia japonica Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- GMMLNKINDDUDCF-JRWRFYLSSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1e)-5-[(r)-methylsulfinyl]-n-sulfooxypentanimidothioate Chemical compound C[S@@](=O)CCCC\C(=N/OS(O)(=O)=O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GMMLNKINDDUDCF-JRWRFYLSSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- QQGLQYQXUKHWPX-SUYBVFMFSA-N benzyl glucosinolate Natural products S(=O)(=O)(O/N=C(/S[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O1)\Cc1ccccc1)O QQGLQYQXUKHWPX-SUYBVFMFSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 239000012990 dithiocarbamate Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- CKIJIGYDFNXSET-MFIRQCQASA-N gluconasturtiin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1S\C(=N\OS(O)(=O)=O)CCC1=CC=CC=C1 CKIJIGYDFNXSET-MFIRQCQASA-N 0.000 description 1
- QQGLQYQXUKHWPX-RFEZBLSLSA-N glucotropeolin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1S\C(=N/OS(O)(=O)=O)CC1=CC=CC=C1 QQGLQYQXUKHWPX-RFEZBLSLSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940100692 oral suspension Drugs 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011257 shell material Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000007944 soluble tablet Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 206010048828 underweight Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- HRHPHXHDSLLZLQ-UHFFFAOYSA-M zinc 2-hydroxypropanoate isothiocyanate Chemical compound C(C(O)C)(=O)[O-].[Zn+2].[N-]=C=S HRHPHXHDSLLZLQ-UHFFFAOYSA-M 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 229940062776 zinc aspartate Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- POEVDIARYKIEGF-CEOVSRFSSA-L zinc;(2s)-2-aminobutanedioate;hydron Chemical compound [Zn+2].[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O POEVDIARYKIEGF-CEOVSRFSSA-L 0.000 description 1
- QPQOIFMSSWHRJQ-UHFFFAOYSA-L zinc;dichlorite Chemical compound [Zn+2].[O-]Cl=O.[O-]Cl=O QPQOIFMSSWHRJQ-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/325—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/362—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/064—Chewing gum characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- This invention relates to an efficacious combination of a zinc salt and an isothiocyanate, and more particularly to an oral composition containing such combination which exhibits increased oral care effects against volatile sulfur compounds (VSCs).
- VSCs volatile sulfur compounds
- Oral malodor or “halitosis” used herein relates to bad breath caused by physiologic (transient or temporary) and/or pathologic conditions.
- Physiological causes of halitosis include: halitosis caused by deleterious habits, morning breath, and xerostomia (dry mouth).
- Pathological causes for halitosis include: secondary or oral tissue conditions associated with gingival and periodontal diseases, acute necrotizing ulcerative gingivitis, residual post-operative blood, debris under dental appliances, ulcerative lesions of the oral cavity, coated tongue, xerostomia, salivary gland diseases and Tonsilloliths (tonsil stones).
- Oral malodors are produced mainly due to the breakdown of proteins into individual amino acids, followed by the further breakdown of certain amino acids to produce detectable foul gases.
- the oral cavity provides a positive growth environment for gram-negative anaerobes that metabolize proteins as an energy source via breakdown of proteinaceous substrates from impacted food particles and sloughed off oral cellular debris. Often, inflammation causes these cells to be shed at a faster rate than the saliva can cleanse. Bacterial action then hydrolyzes the proteins to amino acids; and the amino acids that contain sulfur functional groups, methionine and cysteine, serve as precursors to volatile sulfur compounds (VSCs).
- VSCs volatile sulfur compounds
- VSCs gaseous volatile sulfur compounds
- H 2 S hydrogen sulfide
- CH 3 SH methyl mercaptan
- dimethyl sulfide [(CH 3 ) 2 S] amino acids methionine and cysteine are reduced to hydrogen sulfide and methyl mercaptan, respectively, in the presence of sulfhydrase-positive microbes.
- Methyl mercaptan has been found to be the main component of tongue dorsal surface malodor in patients with periodontal disease, whereas hydrogen sulfide predominates in orally healthy subjects.
- VSCs are also potentially damaging to the tissues in the mouth, and can lead to periodontitis (inflammation of the gums and ligaments supporting the teeth).
- VSCs have been found to damage the collagen and proteoglycan components in connective tissue by cleaving disulfide bonds. This de-aggregation of the extracellular matrix allows microbes to permeate the oral mucosa. As bacteria further accumulates in pockets that form next to the teeth, periodontal disease progresses, as well as halitosis. If the periodontal disease advances significantly, overall systemic health may be jeopardized; for example, periodontal bacterial by-products can enter the blood stream and may result in heart disease, stroke and under-weight babies at birth.
- VSC neutralizing agents such as chlorine dioxide, sodium chlorite, and metal salts such as zinc and copper have been used as VSC neutralizing agents in a variety of oral compositions.
- Such compounds have been provided and are available today as mouthwashes and rinses for the prevention and/or treatment of oral malodor.
- many of the oral rinses available today are used for the prevention and/or treatment of oral malodor or halitosis, but for chronic bad breath, many rinses offer little to no help.
- oral compositions incorporating these compounds which are retained in the mouth for longer periods of time, such as chewing gums, mints, and lozenges, further enhance irritations to the oral cavity when these compounds are employed.
- isothiocyanates can also act as a reagent to remove both intrinsic and extrinsic VSC's, either by conversion of sulfur groups (SH) into the water soluble dithiocarbamate or by formation of the less volatile disulfide.
- SH sulfur groups
- isothiocyanates possess a pungent or irritating odor, and sharp bitter taste. Because of the unpleasant organoleptic attributes, using isothiocyanates in oral compositions is difficult.
- An oral composition containing an effective combination of a zinc salt and an isothiocyanate to reduce volatile sulfur compounds (VSCs) in the oral cavity Moreover, methods for reducing volatile sulfur compounds are also provided.
- FIG. 1 is an illustration of the change of headspace concentration of CH3SH after addition of zinc lactate or zinc gluconate.
- FIG. 2 is a graphical representation of the change of headspace concentration of H2S after addition of zinc salts analyzed by GC-SCD.
- FIG. 3 is an illustration of the different forms of isothiocyanate that result from hydrolyzing glucosinolates.
- FIG. 4 is a graphical representation of Peak Intensity vs. Retention Time (min) from injecting the headspace sample into a GC column with an SCD detector.
- FIG. 5 is a graphical representation of Sweetness Intensity vs. Time (min) for the Control Gum and Experimental Gum A.
- FIG. 6 is a graphical representation of Bitterness Astringency Intensity vs. Time (min) for the Control Gum and Experimental Gum A.
- FIG. 7 is a graphical representation of Off-Flavor Level vs. Time (min) for the Control Gum and Experimental Gum A.
- the present invention relates to an unlikely combination of metal salts and isothiocyanates, effective against multiple volatile sulfur compounds (VSCs) present in the oral cavity. Further, the levels of the metal salts and the isothiocyanates used in combination with one another as described in relation to the invention are lower than each used individually. Accordingly, Applicants invention provides efficacious oral compositions in reducing VSCs, thereby reducing oral malodor.
- VSCs volatile sulfur compounds
- the term “efficacious” means producing or capable of producing a desired effect.
- “effective amount” refers to the level, amount, serving, or percent which produces or is capable of producing a desired effect. All percentages and ratios used herein are by weight of the total composition and all measurements made are at 25° C., unless otherwise designated.
- Zinc salts are incompatible with consumer taste acceptance criteria, effective only for short periods of time or not effective at all in reducing certain volatile sulfur compounds, such as methyl mercaptan (CH 3 SH) when used individually.
- CH 3 SH methyl mercaptan
- Isothiocyanates are volatile compounds, and are classified as either an oral or nasal irritant, or both.
- the pungent sensations of isothiocyanates may be sensed throughout the oral mucosal tissues, including the upper respiratory tract.
- breath freshening benefits will last for at least about 15 minutes, typically for at least about 30 minutes, and preferably for at least about 60 minutes after consumption or mastication of the oral composition.
- breath freshening will continue after consumption or mastication for at least about 60 minutes, maintaining a total VSC reduction of at least 50%.
- total VSC includes two or more of the following VSCs: hydrogen sulfide (H 2 S), methyl mercaptan (CH 3 SH) and dimethyl sulfide [(CH 3 ) 2 S] in any combination.
- breath freshening benefits will continue after 120 minutes with a total VSC reduction of at least 40% and preferably after 180 minutes with a total VSC reduction of at least 20% after consumption or mastication of the oral composition.
- various embodiments of the invention provide an effective amount of zinc lactate, zinc gluconate, zinc ascorbate, or zinc aspartate and mixtures thereof, in combination with an isothiocyanate to inhibit or ameliorate multiple volatile sulfur compounds in an oral composition at a combined concentration of less than 0.50% by weight.
- an oral composition of the present invention can take any physical form suitable for application to an oral surface of humans, dogs, cats, or other animals and provides either a cosmetic prophylactic or therapeutic benefit within or derived from the oral cavity.
- an oral composition of the invention can be a dentifrice such as a powder or paste; an edible film or bioadhesive film; a confectionary composition including but not limiting to breath mints, low boiled candy, chewing gum, chewy candy, hard boiled candy, coated candy, lozenges, syrups, pressed mints, throat drops, and chocolates; pet foods, chews or biscuits and the like.
- the consuming or masticating of the oral composition may be repeated at regular intervals.
- Applicants have identified suitable, efficacious, and consumer acceptable levels of including both zinc salts and isothiocyanates for use in various oral compositions to reduce multiple VSCs in the oral cavity.
- an effective amount of a zinc salt may be used to inhibit volatile sulfur compounds in the oral cavity, thereby reducing oral malodor.
- organic zinc salts for VSC reduction include zinc gluconate (average zinc ion content of 12.8%), zinc lactate (average zinc ion content of 23.2%), zinc ion acetate (average zinc ion content of 29.8%), and zinc citrate (average zinc ion content of 32.2%); although based on the Applicants' research (as provided in more detail below), not all zinc salts are effective against all types of VSCs. Under normal circumstances, zinc salts containing a high level of zinc ion perform better than a zinc salt containing low level of zinc ion.
- Suitable zinc salts for use in these formulations include zinc acetate (molar solubility in water of 1.64 moles/l), zinc citrate (molar solubility in water of ⁇ 0.1 moles/l), zinc gluconate (molar solubility in water of 0.28 moles/l), and zinc lactate (molar solubility in water of 0.17 moles/l). Normally, a zinc salt with better water solubility performs better than a zinc salt with poor water solubility.
- Metal salts such as zinc salts have the ability to chelate VSCs present in the oral cavity and form non-volatile metal ion-sulfide complexes, thereby neutralizing oral malodor. However, this ability to neutralize oral malodor is temporary.
- the metal salts do not change mouth conditions, and do not exhibit activity against odor producing bacteria present in the oral cavity. Accordingly, oral hygiene products containing zinc salts, such as zinc chloride mouthwashes, are considered by some to be effective for halitosis, but for many, they are not effective and only have temporary effects.
- Applicants have identified that some zinc salts are not effective against all VSCs, such as hydrogen sulfide (H 2 S), dimethyl sulfide [(CH 3 ) 2 S], and methyl mercaptan (CH 3 SH), but instead may only be effective against specific VSCs.
- H 2 S hydrogen sulfide
- CH 3 SH dimethyl sulfide
- CH 3 SH methyl mercaptan
- the Applicants established an in vitro method using a headspace gas-chromatograph equipped with a sulfur detector.
- PBS phosphate buffer solution
- the pH was maintained at 7.4.
- Different amounts of zinc lactate or zinc gluconate were added into the test tube and mixed for 5 minutes at 37° C.
- the headspace sample was injected into a gas chromatograph sulfur chemiluminescence detector (GC-SCD).
- FIG. 1 below shows the testing result.
- zinc lactate reduces H 2 S at concentrations greater than 0.25 mg, and zinc gluconate, zinc hydrogen aspartate, and zinc ascorbate at concentrations greater than 0.5 mg in vitro.
- salts of metal cations such as aluminum sulfate and zinc chlorite, zinc lactate, zinc acetate, and the like, are often unpleasant or unpalatable to many consumers. Due to this undesirable effect caused by products containing metal salts, and in consideration of the temporary halitosis neutralization benefits, consumer motivation to purchase and use products containing these ingredients in the treatment of oral malodor is low.
- Isothiocyanates are volatile compounds, and are classified as either an oral or nasal irritant, or both. The pungent sensations of isothiocyanates may be sensed throughout the mucosal tissues of the mouth as well as in the upper respiratory tract. Isothiocyanates are bound as precursors in whole vegetables and are released through enzymatic action when the plant materials are ground. Isothiocyanates are biologically active hydrolysis (breakdown) products of glucosinolates.
- Cruciferous vegetables such as broccoli, cauliflower, kale, turnips, collards, brussel sprouts, cabbage, kohlrabi, rutabaga, Chinese cabbage, and bok choy contain a variety of glucosinolates, each of which forms a different isothiocyanate when hydrolyzed and is illustrated in FIG. 3 .
- broccoli is a good source of glucoraphanin, the glucosinolate precursor of sulforaphane (SFN), and sinigrin, the glucosinolate precursor of allyl isothiocyanate (AITC).
- AITC allyl isothiocyanate
- Watercress is a rich source of gluconasturtiin, the precursor of phenethyl isothiocyanate (PEITC), while garden cress is rich in glucotropaeolin, the precursor of benzyl isothiocyanate (BITC). Studies have shown that these compounds are responsible for the unpleasant taste of cruciferous vegetables, raw or cooked.
- Natural Isothiocyanates useful in this invention include the following myrosinase-catalyzed glucosinolate compounds from the plant family Brassicaceae: sulforaphane (SFN), allyl isothiocyanate (AITC), phenethyl isothiocyanate (PEITC), benzyl isothiocyanate (BITC), as shown in FIG. 3 .
- Preferable natural isothiocyanates useful in this invention are allyl isothiocyanates, also known as mustard oils, and commonly found in horseradish, and wasabi.
- the term “natural” means a chemical compound or substance produced by a living organism and found in nature, which may possess a pharmacological or biological activity for use in pharmaceutical drug discovery and drug design.
- a product may be considered as “natural” although the product is prepared by total synthesis if the components are substantially identical to a substance found in nature.
- Examples of synthetic or non-natural isothiocyanates include 3-morpholinopropyl isothiocyanate, phenylisothiocyanate, and norbornyl isiocyanate ([endo-2-acetyl-exo-6-isothiocyanatonorbornane, exo-2-acetyl-exo-6-isothiocyanatonorbornane, exo-2-acetyl-exo-5-isthiocyantonorbornane], which can be synthesized from sulforaphane or from commercially available 2-acetyl-5-norbornene).
- a stock solution of H 2 S was prepared by a serial dilution in PBS buffer (pH 7.4), with a final concentration of 200 ppm. Allyl isothiocyanate, benzyl isothiocyanate, ethyl isothiocyanate and 3-methylthiopropyl isothiocyanate (all from Sigma-Aldrich) were dissolved in pure ethanol to form 1.0% of working solution of each.
- a total of 5 ml PBS buffer containing 200 ppm of H 2 S in a headspace vial (22 ml volume) was mixed with 0.125, 0.25, 0.5 and 1 mg of each isothiocyanate compound for 5 min at 37° C., respectively.
- the headspace sample was injected into the GC-SCD by an automatic sampler for VSC analysis. The reduction of headspace concentration of H 2 S was calculated by the formula below:
- Table 1 above indicates that the isothiocyanates tested aid in reducing hydrogen sulfide (H 2 S).
- H 2 S hydrogen sulfide
- benzyl isothiocyanate demonstrated a reduction of H 2 S of greater than 50%. More significantly, ethylisothiocyanate reduced the headspace of H 2 S by 68% at 200 ppm; 3-methylthiopropyl isothiocyanate reduced the headspace of H 2 S by 75% at 100 ppm, and 94.5% at 200 ppm.
- allyl isothiocyanate (AITC) showed a strong reduction of H 2 S (greater than 90% at 100 ppm or greater).
- Applicants further evaluated allyl isothiocyanate in vitro for its VSC elimination effect of hydrogen sulfide (H 2 S).
- H 2 S hydrogen sulfide
- a stock of hydrogen sulfide solutions were prepared by dissolving c.a. 0.10 g of sodium sulfide in a total of 10 ml phosphate buffer solution (PBS) (pH 7.4). It was further diluted in PBS to produce a working solution contained 200 ppm of H 2 S in buffer.
- PBS ml phosphate buffer solution
- Table 2 indicates that allyl isothiocyanate (AITC) reduces oral malodor associated with hydrogen sulfide (H 2 S) at concentrations greater than 0.25 mg (or 50 ppm) in vitro.
- AITC allyl isothiocyanate
- allyl isothiocyanate was further evaluated for in vivo breath freshening effects.
- Chewing gum containing 100 ppm of allyl isothiocyanate (AITC) was prepared in the laboratory, and was rolled, sheeted, and cut into sticks with a weight average of 2.7 g.
- a randomized, double-blind clinical study was conducted for evaluation of chewing gum containing allyl isothiocyanate (AITC). A total of 15 subjects met inclusion and exclusion criteria were recruited and completed the study. Subjects were instructed to refrain from oral hygiene, eating and drinking to the testing site.
- One piece of gum (piece weight: 2.7 g) containing 0.27 mg of allyl isothiocyanate were chewed for 20 minutes and the residual gum cud analyzed by gas chromatography. Results were compared with extraction of unchewed gum from which recovery was 48.5%. The release of allyl isothiocyanate from the gum was found to be 69.6% after 20 minutes of chewing.
- isothiocyanates such as allyl isothiocyanate show ability in reducing VSCs (such as H 2 S)
- VSCs such as H 2 S
- isothiocyanates impart pungent aroma, spicy, bitter taste, and are irritating to both the oral and the mucous membranes; even when consumed at low levels.
- the levels shown to be efficacious would impart unpleasant taste and other negative organoleptic properties to a consumer. It is understood that the effective concentrations of isothiocyanates demonstrated is constrained by the need to provide oral malodor reduction without adversely affecting the appearance, taste, color or texture of various oral compositions.
- VSCs volatile sulfur compounds
- zinc salts or isothiocyanates may be effective for short periods of time or not effective at all in reducing certain volatile sulfur compounds (such as methyl mercaptan (CH 3 SH)).
- CH 3 SH methyl mercaptan
- Applicants combination of both compounds provide for efficacious amelioration of multiple VSCs for extended periods of time, even post-mastication or consumption.
- the combination of metal salts and isothiocyanates yield an organoleptically pleasing taste that is acceptable by consumers compared to when each of the compounds are used individually, at higher levels.
- compositions useful to the invention comprise a zinc salt and a compound extracted from mustard oil, such as such allyl isothiocyanate, (“AITC”) or a synthetic or semi-synthetic equivalent of such a component or compound thereof.
- AITC allyl isothiocyanate
- a synthetic or semi-synthetic equivalent of such a component or compound thereof may be extracts of mustard oils.
- an effective concentration of zinc lactate and allyl isothiocyanate in an oral composition of this invention depends not only upon the relative concentration at which enhancement of activity against volatile sulfur compounds is achieved, but also when a consumer acceptable taste is provided.
- an enhanced weight ratio of zinc salt/isothiocyanate in an oral composition is at least 0.1:1, typically at least 0.5:1 and preferably at least 1:1. This weight ratio may range up to 100:1 or above, typically up to 1:1, preferably up to 10:1. A typical weight ratio range is between 0.5:1 to about 50:1 and preferably 1:1 to 20:1.
- the ratio of zinc salt to isothiocyanate is between 1:1 to about 20:1 wherein the zinc salt is an organic zinc salt, and the isothiocyanate is allyl isothiocyanate.
- the zinc salt is present in the oral composition in an amount of about 0.001 to about 0.50 wt. %. Such a concentration is dependent upon the concentration of the isothiocyanate employed for enhanced results against volatile sulfur compounds (VSCs).
- the zinc salt is present in the oral composition in an amount of about 0.001 to about 1 wt. %. In other embodiments, the zinc salt is present at less than 0.50 wt. %, for example the zinc salt is present at a concentration of in an amount of about 0.01 to about 0.25 wt. %.
- zinc lactate is present in the oral composition at a concentration of about 0.10 wt. %. Overall, the concentration of zinc salt is below a level which produces an objectionable taste.
- the zinc salt may be a commonly used organic zinc salt, including zinc gluconate, zinc lactate, zinc acetate, zinc citrate, and combinations thereof.
- the isothiocyanate is present in the oral composition in an amount of about 0.001% to about 1 wt. %. In other embodiments, the isothiocyanate present at less than 1%. In one preferred embodiment, the allyl isothiocyanate is present in the oral composition at a concentration of about 0.01 wt. %. Allyl isothiocyanate may be determined by a gas chromatograph-mass spectrophotometer (GC-MS).
- GC-MS gas chromatograph-mass spectrophotometer
- the isothiocyanate may be natural or non-natural, including but not limiting to sulforaphane (SFN), allyl isothiocyanate (AITC), phenethyl isothiocyanate (PEITC), benzyl isothiocyanate (BITC), 3-morpholinopropyl isothiocyanate, phenylisothiocyanate, and norbornyl isiocyanate ([endo-2-acetyl-exo-6-isothiocyanatonorbornane, exo-2-acetyl-exo-6-isothiocyanatonorbornane, exo-2-acetyl-exo-5-isthiocyantonorbornane], which can be synthesized from sulforaphane or from commercially available 2-acetyl-5-norbornene), alone or in any combination.
- SFN sulforaphane
- AITC allyl isothiocyanate
- PEITC
- Oral compositions useful in this invention contain a VSC reducing effective amount of a zinc salt and an isothiocyanate combined with a suitable carrier.
- a suitable carrier typically is a food-acceptable or food contact acceptable material in which the zinc salt and isothiocyanate used in the invention may be incorporated or dispersed without adverse effect.
- a typical suitable carrier is a water-soluble solid or chewable solid such as a confectionery composition.
- Another suitable carrier is a dentifrice such as a past or powder.
- Other suitable carriers for cats, dogs and other animals include but are not limited to chews, biscuits, kibble (dry), and canned (wet/soft) pet foods.
- confectionery composition includes chewing gums, and orally soluble tablets, beads and lozenges.
- Saliva dissolves the lozenge or chewable gum product, and promotes prolonged contact with oral surfaces so that the delivery of the VSC reducing agents in a lozenge tablet, bead or chewing gum form ensures that an adequate dosage of the active ingredients are delivered to the oral surface when the product is used.
- the confectionery composition may be in the form of a coating, shell, film, syrup or suspension.
- an oral composition is a chewing gum composition which is suitable for chewing and which comprises 2% or greater, by weight of the composition, of elastomer.
- chewing gum compositions are chewed or masticated by consumers, the process by which food is mashed and crushed by teeth.
- Such chewing gum compositions can take a variety of shapes and forms, for example, a pellet, a gumball, a square, a stick, etc., and may be coated by a variety of materials including but not limiting to sugars, polyols, chocolates, syrups, films, and the like, alone or in any combination. Natural or artificial colors and combinations thereof, high intensity sweeteners and flavors may also be added to the coating solution.
- zinc salts may be incorporated in a coating or in a center.
- a chewing gum useful to the invention is a sugarless chewing gum containing a zinc salt and an isothiocyanate to reduce VSCs.
- Chewing gum formulations typically contain, in addition to, a chewing gum base, one or more plasticizing agents, at least one sweetening agent and at least one flavoring agent.
- a chewing gum containing zinc lactate from about 0.002% to about 2% by weight, and allyl isothiocyanate from of 0.001% to about 5% by weight, wherein the chewing gum provided a reduction in multiple VSCs up to 180 minutes after chewing.
- a chewing gum composition wherein the zinc salt is at a concentration of about 0.10% by weight, and the isothiocyanate is at a concentration of about 0.01% by weight.
- the isothiocyanate provided may comprise multiple isothiocyanates, natural or non-natural, and combinations thereof.
- the chewing gum is masticated for at least 5 minutes, for at least 10 minutes, or for at least 15 minutes. Total VSC reduction occurs immediately after post-mastication, or for at least 30 minutes, 60 minutes, typically for at least 90 minutes, and preferably for at least 120 minutes.
- the allyl isothiocyanate has at least 50% release from a chewing gum into the oral cavity of the user.
- a hard sugarfree candy containing less than 0.50% by weight zinc salt, and less than 1% by weight isothiocyanate.
- VSC effective anti-volatile sulfur compound level
- the level of allyl isothiocyanate is less than 50 ppm in an oral composition.
- an effective enhanced breath freshening level of zinc lactate against VSCs is between 100 ⁇ g/mL to about 2000 ⁇ g/mL and the isothiocyanate is selected from the group consisting of allyl isothiocyanate, benzyl isothiocyanate, phenethyl isothiocyanate, and sulforphane, wherein the level of isothiocyanate is between 10 ⁇ g/mL to about 500 ⁇ g/mL.
- an oral suspension wherein a zinc salt is provided at about 1250 ⁇ g/mL, and the non-natural isothiocyanate is provided at about 1000 ⁇ g/mL.
- a mixture of hydrogen sulfide (H 2 S) and methyl mercaptan (CH 3 SH) was prepared by mixing 5 parts of H 2 S and 1 part of CH 3 SH in an aqueous phosphate buffer solution (PBS) at pH 7.4.
- the final concentrations of H 2 S and CH 3 SH in solution were a 200 and 40 ppm, respectively.
- the final amount of VSC was 1.2 mg in the test vial.
- the headspace concentrations of H 2 S and CH 3 SH were well above the level found in a typical foul mouth air (200-500 parts per billion), the total amount of VSC was close to the amount presented in oral cavity.
- FIG. 4 demonstrates allyl isothiocyanate (AITC) and zinc lactate (ZnL or ZL) exhibit an enhanced effect on multiple VSCs (H 2 S and CH3SH); 1 mg of AITC eliminates 98% of H 2 S and 78% of CH 3 SH; 1 mg of ZL eliminates 98% of H 2 S, 0% of CH 3 SH.
- AITC allyl isothiocyanate
- ZnL or ZL zinc lactate
- gum base was heated to 85° C. in a gum mixer.
- Zinc lactate, sorbitol, intense sweeteners, glycerin and sorbitol syrup were added to the warmed gum base.
- Allyl-isothiocyanate (AITC) was added to the flavor and stirred well before added to the gum mixer.
- the gum bolus was sheeted and cut to sticks. Each stick gum weighs 2.7 gram.
- Table 5 shows the formulas of experimental gum:
- FIGS. 5-7 show no significant difference observed for off-flavor (including astringency) and bitterness between the experimental gum-A and the control gum. No significant difference in sweetness intensity was observed as well.
- a randomized, double-blind clinical study was conducted for evaluation of chewing gum containing zinc lactate and allyl isothiocyanate (AITC).
- AITC zinc lactate and allyl isothiocyanate
- a total of 15 subjects met inclusion and exclusion criteria were recruited and completed the study.
- Subjects were instructed to refrain from oral hygiene, eating and drinking to the testing site.
- Each subject exhaled his/her breath to a gas chromatograph to analyze for baseline VSC.
- Subject was then chewed 1 dose of experimental gum (or control gum) for 12 minutes.
- Subject exhaled his/her breath to the gas chromatograph immediately after chew, and 60, 120 and 180 minutes. Each test was repeated twice. There were at least two days between treatments. Table 6 below shows the clinical testing results.
- Gum base did not show statistically significant reduction of oral malodor, measured by total concentration of VSCs using a gas chromatograph at 60, 120 and 180 min.
- the gum base actually increased VSCs by 3%, 44% and 46% at 60, 120 and 180 min, respectively.
- Chewing gums containing AITC alone reduced oral malodor by 67%, 32%, 29% and 9% at immediately after chew, 60, 120, and 180 min, respectively.
- a chewing gum is provided containing less than 0.2% by weight zinc salt, and less than 0.02% by weight isothiocyanate providing breath freshening benefits after consumption to an individual for at least about 2 hours.
- Gum base materials suitable for use in the practice of this invention are well known in the art and include natural or synthetic gum bases or mixtures thereof.
- the gum base may be incorporated in the chewing gum product at a concentration of about 10 to about 40 wt. % and preferably about 20 to about 35 wt. %.
- Plasticizing/softening agents commonly used in chewing gum compositions are suitable for use in this invention, including gelatin, waxes and mixtures thereof in amounts of about 0.1 to about 5%.
- the sweetening agent ingredient used in the practice of this invention may be selected from a wide range of materials, and include the same artificial and polyol sweeteners used for the preparation of tablets, beads and lozenges.
- Polyol sweeteners such as sorbitol and maltitol are present in the chewing gum composition of the invention in amounts of about 40 to about 80 wt. % and preferably about 50 to about 75 wt. %.
- the artificial sweetener is present in the chewing gum composition of the invention in amounts of about 0.1 to about 2 wt. % and preferably about 0.3 to about 1 wt. %.
- Coating material appreciated by those skilled in the art include, but are not limited to waxes, shellac, polyols, carboxymethyl cellulose, polyethylene/malic anhydride copolymer or kappa-carrageenan
- an oral composition of this invention may further comprise a trigeminal stimulant or sensate including but not limited to menthol and other cooling compounds such as WS-23 and other cooling carboxamide compounds and pungent compounds including but not limiting to capsaicinoids and piperines.
- a trigeminal stimulant or sensate including but not limited to menthol and other cooling compounds such as WS-23 and other cooling carboxamide compounds and pungent compounds including but not limiting to capsaicinoids and piperines.
- the invention may be provided in various oral compositions. Accordingly, various embodiments of the invention is illustrated, but not limited by, the following Examples.
- compositions E, F & G A chewing gum formulation (designated “Compositions E, F & G”) containing isothiocyanates and zinc salts.
- Composition H compressed tablet formulation containing allyl isothiocyanate and zinc citrate:
- composition I This invention is illustrated, but not limited by, the hard candy formulation (designated “Composition I”) below:
- composition J This invention is illustrated but not limited by, the dog biscuit formulation (designated “Composition J”).
- the dog biscuit was prepared according to conventional techniques; and comprises the following ingredients:
Abstract
Description
TABLE 1 |
In vitro reduction of hydrogen sulfide (H2S) by |
allyl isothiocyanate, benzyl isothiocyanate, ethyl |
isothiocyanate and 3-methylthiopropyl isothiocyanate: |
% Reduction of | |||
Sample | Amount | Peak Area | headspace concentration |
Control | 200 ppm | 853223827 | 0% |
Allyl isothiocyanate | 50 ppm | 431713256 | 49% |
100 ppm | 13651581 | 98.4% | |
200 ppm | 4266119 | 99.5% | |
Benzyl | 25 ppm | 491908604 | 42% |
isothiocyanate | 50 ppm | 398519292 | 53% |
Ethylisothiocyanate | 50 ppm | 963110533 | −13% |
100 ppm | 726258436 | 14.9% | |
200 ppm | 271822727 | 68% | |
3-methylthiopropyl | 50 ppm | 416687277 | 51 |
isothiocyanate | |||
100 ppm | 211177117 | 75% | |
200 ppm | 46897168 | 94.5% | |
TABLE 2 |
In vitro reduction of hydrogen sulfide |
(H2S) by allyl isothiocyanate (AITC) |
Allyl isothiocyanate | Reduction of H2S | ||
0 mg | 0.0% | ||
0.25 mg | 49.0% | ||
0.5 mg | 98.4% | ||
1 mg | 99.5% | ||
TABLE 3 |
In vivo reduction of H2S using chewing gum |
containing 100 ppm of allyl isothiocyanate (AITC) |
Gum-base1 (no | |||
AITC, flavor, or | Control | Experimental | |
sweeteners) | gum (no AITC) | (100 ppm AITC) | |
|
0% | 0% | 0% |
Immediate after | 1% | 39% | 60%† |
chew | |||
60 min | −10% | 10% | 28% |
120 min | −35% | −18% | 23% |
180 min | −39% | −20% | 2% |
1Results from previous study | |||
†Statistical significant compared with baseline | |||
*Statistically significant compared with control gum |
TABLE 4 |
In vivo reduction of CH3SH using chewing gum |
containing 100 ppm of allyl isothiocyanate (AITC) |
Gumbase1 (no AITC, | Experiemental | ||
flavor, or | Control gum | gum | |
sweeteners) | (No AITC) | (100 ppm AITC) | |
|
0% | 0% | 0% |
Immediate after | 8% | 56%† | 73%† |
chew | |||
60 min | −24% | 3% | 46%† |
120 min | −110% | −64% | 32% |
180 min | −90% | −73% | 12% |
1Results from previous study | |||
†Statistical significant compared with baseline | |||
* Statistically significant compared with control gum |
TABLE 5 | |||
Experimental | Experimental | ||
Ingredient | Control Gum | Gum A | Gum B |
Sorbitol | 33.10% | 32.95% | 31.73% |
Gum base | 31.00% | 31.00% | 30.00% |
Sorbitol Syrup | 33.40% | 33.40% | 33.00% |
Glycerin | 0.90% | 0.90% | 0.90% |
Zinc Lactate | — | 0.10% | 0.10% |
Encapsulated high intensity | 0.35% | 0.35% | 1.1% |
sweetener | |||
High intensity sweetener | 0.16% | 0.16% | 0.16% |
Banana flavor | 1.00% | 1.00% | — |
Peppermint oil | — | — | 3.00% |
AITC (added to flavor oil) | — | 0.01% | 0.01% |
Total | 100.0% | 100.0% | 100.0% |
TABLE 6 |
Reduction (or increment) of total VSC after treatment |
Test Gum D | ||||
Test Gum C | (0.01% AITC | |||
Gumbase | Control gum | (0.01% AITC) | 0.1% ZL) | |
|
0% | 0% | 0% | 0% |
Immediately | 15% | 46%* | 67%* | 87%*† |
after chew | ||||
60 min | −3% | 14% | 32%* | 56%*† |
120 min | −44% | −23% | 29%* | 48%*† |
180 min | −46% | −27% | 9% | 24%*† |
(*2-tail p < 0.05 compared with baseline; †2-tail p < 0.05 compared with the control gum) |
E | F | G | |
Ingredients | Weight % | Weight % | Weight % |
Gum Base | 27.5 | 30.00 | 24.34 |
Sorbitol | 60.00 | 56.88 | 58.00 |
Mannitol | 1.00 | — | 3.00 |
Lycasin/Glycerin | 8.44 | 9.50 | 12.00 |
Sweetener | 0.80 | 0.85 | 0.80 |
Flavor | 1.75 | 2.00 | 1.75 |
Allyl isothiocyanate (AITC) | 0.005 | 0.01 | |
Benzyl isothiocyanate | 0.02 | ||
(BITC) | |||
3-morpholinopropyl | 0.005 | ||
isothiocyanate | |||
Zinc lactate | 0.10 | ||
Zinc citrate | 0.50 | ||
Zinc acetate | 0.75 | ||
Ingredients | Weight % | ||
Sorbitol | 97.14 | ||
Magnesium Stearate | 1.00 | ||
Peppermint Oil | 0.10 | ||
Sweeteners | 1.00 | ||
Zinc citrate | 0.75 | ||
Allyl isothiocyanate (AITC) | 0.01 | ||
Ingredients | Weight % | ||
Isomalt | 97.83 | ||
Xylitol | 1.05 | ||
High intensity sweetener | 0.07 | ||
Flavor | 0.04 | ||
Zinc lactate | 1.00 | ||
Phenethyl isothiocyanate | 0.01 | ||
Ingredients | Weight % | ||
Ground Wheat | 30.0 | ||
Oats & Bran | 17.0 | ||
Grits & Seeds | 16.5 | ||
Gluten | 7.5 | ||
Sugar | 6.0 | ||
Fat | 5.0 | ||
Aromas, Flavors | 7.5 | ||
Vitamins & Minerals | 9.95 | ||
Zinc lactate | 0.50 | ||
Allyl isothiocyanate (AITC) | 0.05 | ||
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/234,517 US10543155B2 (en) | 2011-07-26 | 2012-07-10 | Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (VSCs) |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161511646P | 2011-07-26 | 2011-07-26 | |
US14/234,517 US10543155B2 (en) | 2011-07-26 | 2012-07-10 | Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (VSCs) |
PCT/US2012/046071 WO2013015979A2 (en) | 2011-07-26 | 2012-07-10 | Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (vscs) |
Publications (2)
Publication Number | Publication Date |
---|---|
US20140294739A1 US20140294739A1 (en) | 2014-10-02 |
US10543155B2 true US10543155B2 (en) | 2020-01-28 |
Family
ID=47601714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/234,517 Active 2033-07-03 US10543155B2 (en) | 2011-07-26 | 2012-07-10 | Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (VSCs) |
Country Status (9)
Country | Link |
---|---|
US (1) | US10543155B2 (en) |
EP (1) | EP2736520B1 (en) |
CN (1) | CN103717225B (en) |
AU (1) | AU2012287333B2 (en) |
CA (1) | CA2842745C (en) |
MX (1) | MX362350B (en) |
PL (1) | PL2736520T3 (en) |
RU (1) | RU2573987C2 (en) |
WO (1) | WO2013015979A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106806886B (en) * | 2015-12-01 | 2021-07-16 | 华中科技大学 | Breath freshener for quickly eliminating halitosis and medical application thereof |
CN108852909B (en) * | 2018-08-01 | 2021-11-23 | 海南医学院 | Toothpaste for preventing dental caries and preparation method thereof |
US20210060058A1 (en) * | 2019-09-04 | 2021-03-04 | Unm Rainforest Innovations | Compositions and methods for treating hydrogen sulfide-mediated hyperdynamic circulation |
CN112076165B (en) * | 2020-09-08 | 2022-05-13 | 北京哈三联科技有限责任公司 | Orally disintegrating tablet capable of freshening breath and preparation method thereof |
WO2022216769A1 (en) * | 2021-04-07 | 2022-10-13 | Fontana Biosciences, Inc. | Rapidly disintegrating allyl isothiocyanate tablet |
CN113176359A (en) * | 2021-06-16 | 2021-07-27 | 山东京博石油化工有限公司 | Method for evaluating sulfide content in asphalt volatile matter by using headspace gas chromatography |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11246319A (en) | 1998-02-27 | 1999-09-14 | Ogawa Koryo Co Ltd | Antimicrobial and antifungal agent |
WO2000000166A2 (en) * | 1998-06-29 | 2000-01-06 | Warner-Lambert Company | Improved oral compositions for control and prevention of tartar, oral malodor, plaque and gingivitis |
JP2000086414A (en) | 1998-09-04 | 2000-03-28 | Kinjirushi Wasabi Kk | Antimicrobial agent superior in bacteriostatic action and antibacterial activity |
WO2000051559A1 (en) | 1999-03-01 | 2000-09-08 | Orix As | Oral composition for inhibiting oral malodor |
US20020122843A1 (en) | 2000-12-27 | 2002-09-05 | Mcgrew Gordon N. | Chewing gums and related products that provide breath freshening characteristics |
US20030211209A1 (en) | 1999-11-18 | 2003-11-13 | The Procter & Gamble Co. | Products comprising an isothiocyanate preservative system and methods of their use |
US20060264497A1 (en) | 2005-03-28 | 2006-11-23 | Zeligs Michael A | Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
US20070053849A1 (en) * | 2000-06-30 | 2007-03-08 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
GB2436463A (en) | 2006-03-21 | 2007-09-26 | Biofilm Ltd | Breath deodoriser |
US20080253976A1 (en) * | 2007-04-16 | 2008-10-16 | Douglas Craig Scott | Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof |
US20100172941A1 (en) * | 2009-01-05 | 2010-07-08 | Michael Vajdy | Adjuvant Compositions and Methods of Use |
WO2010140272A1 (en) | 2009-06-02 | 2010-12-09 | 金印株式会社 | Deodorizing agent comprising ω-methylthioalkylisothiocyanate |
US20120164268A1 (en) * | 2009-09-02 | 2012-06-28 | Sarah Pearson | Confectionery Composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3940476A (en) * | 1972-03-20 | 1976-02-24 | General Foods Corporation | Oral preparations for preventing dental plaque |
JP3197873B2 (en) | 1993-06-30 | 2001-08-13 | 三洋電機株式会社 | Power supply circuit design method and power supply circuit |
US6723305B2 (en) * | 2002-03-04 | 2004-04-20 | Colgate Palmolive Company | Anti-microbial breath freshening mouthrinse |
-
2012
- 2012-07-10 RU RU2014103675/15A patent/RU2573987C2/en active
- 2012-07-10 AU AU2012287333A patent/AU2012287333B2/en active Active
- 2012-07-10 PL PL12818073T patent/PL2736520T3/en unknown
- 2012-07-10 CA CA2842745A patent/CA2842745C/en active Active
- 2012-07-10 MX MX2014000904A patent/MX362350B/en active IP Right Grant
- 2012-07-10 EP EP12818073.4A patent/EP2736520B1/en active Active
- 2012-07-10 US US14/234,517 patent/US10543155B2/en active Active
- 2012-07-10 CN CN201280037437.1A patent/CN103717225B/en active Active
- 2012-07-10 WO PCT/US2012/046071 patent/WO2013015979A2/en active Application Filing
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11246319A (en) | 1998-02-27 | 1999-09-14 | Ogawa Koryo Co Ltd | Antimicrobial and antifungal agent |
WO2000000166A2 (en) * | 1998-06-29 | 2000-01-06 | Warner-Lambert Company | Improved oral compositions for control and prevention of tartar, oral malodor, plaque and gingivitis |
JP2000086414A (en) | 1998-09-04 | 2000-03-28 | Kinjirushi Wasabi Kk | Antimicrobial agent superior in bacteriostatic action and antibacterial activity |
WO2000051559A1 (en) | 1999-03-01 | 2000-09-08 | Orix As | Oral composition for inhibiting oral malodor |
US20030211209A1 (en) | 1999-11-18 | 2003-11-13 | The Procter & Gamble Co. | Products comprising an isothiocyanate preservative system and methods of their use |
US20070053849A1 (en) * | 2000-06-30 | 2007-03-08 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
US20020122843A1 (en) | 2000-12-27 | 2002-09-05 | Mcgrew Gordon N. | Chewing gums and related products that provide breath freshening characteristics |
US20060264497A1 (en) | 2005-03-28 | 2006-11-23 | Zeligs Michael A | Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
GB2436463A (en) | 2006-03-21 | 2007-09-26 | Biofilm Ltd | Breath deodoriser |
US20080253976A1 (en) * | 2007-04-16 | 2008-10-16 | Douglas Craig Scott | Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof |
US20100172941A1 (en) * | 2009-01-05 | 2010-07-08 | Michael Vajdy | Adjuvant Compositions and Methods of Use |
WO2010140272A1 (en) | 2009-06-02 | 2010-12-09 | 金印株式会社 | Deodorizing agent comprising ω-methylthioalkylisothiocyanate |
US20120164268A1 (en) * | 2009-09-02 | 2012-06-28 | Sarah Pearson | Confectionery Composition |
Non-Patent Citations (9)
Title |
---|
Aires et al (J Appl Microbiol, 106 (6), 2086-2094 (Year: 2009). * |
Eger, et al., "Metal-Mediated Reaction Modeled on Nature: The Activation of Isothiocyanates Initiated by Zinc Thilate Complex," Inorg. Chem., 2011, vol. 50, pp. 3223-3233. |
Keast RSJ, The effect of zinc on human taste perception, Journal of Food Science, 68(5), 2006, 1871. * |
LKT Laboratories, http://www.lktlabs.com/products/Phenyl_isothiocyanate_Phenyl_mustard_oil-159-48.html, Dec. 31, 2010. * |
Mintel, "Healthy Milk Powder for Woman", retrieved at http:\\www.gnpd.com, Apr. 2006, 2 pages. |
Mintel, "Multi-Nutrient Tablets", retrieved at http:\\www.gnpd.com, Sep. 2010, 4 pages. |
Pier Francesco Porciana and Simone Grandini, The Effect of Zinc Acetate and Magnolia Bark Extract Added to Chewing Gum on Volatile Sulfur-Containing Compounds in the Oral Cavity, Journal of Clinical Dentistry, 2012, vol. 23, pp. 76-79, retrieved from www.jclindent.com/Fastrak/FT_23.3_Porciani.pdf on Oct. 6, 2014. |
Tian, et al., "Chewing gum containing allyl isothiocyanate from mustard seed extract is effective in reducing volatile sulfur compounds responsible for oral malodor," Am. J. Dent., 2013, vol. 26, pp. 180-184. |
Zhang Y, Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates, PNAS, 1994, 91, 3147-3150. * |
Also Published As
Publication number | Publication date |
---|---|
WO2013015979A3 (en) | 2013-05-10 |
MX2014000904A (en) | 2015-04-10 |
EP2736520B1 (en) | 2020-09-09 |
CA2842745C (en) | 2018-01-09 |
AU2012287333A1 (en) | 2013-05-02 |
RU2573987C2 (en) | 2016-01-27 |
RU2014103675A (en) | 2015-09-10 |
US20140294739A1 (en) | 2014-10-02 |
CN103717225B (en) | 2016-09-28 |
AU2012287333B2 (en) | 2016-02-25 |
CA2842745A1 (en) | 2013-01-31 |
EP2736520A4 (en) | 2015-07-08 |
CN103717225A (en) | 2014-04-09 |
MX362350B (en) | 2019-01-11 |
EP2736520A2 (en) | 2014-06-04 |
WO2013015979A2 (en) | 2013-01-31 |
PL2736520T3 (en) | 2020-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10543155B2 (en) | Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (VSCs) | |
US6746697B2 (en) | Composition containing Heliopsis longipes root extract and oral carrier | |
US8512681B2 (en) | Chewing gum possessing tooth cleaning effect and a teeth cleaning method | |
ES2656187T3 (en) | Rubber compositions moisturizing the mouth and products containing them | |
JP7413465B2 (en) | Composition for preventing or treating oral diseases | |
JPH07108851B2 (en) | Oral composition for preventing solid pimples | |
JP2021506738A (en) | Refreshing and flavor-enhancing composition | |
JP2004532831A (en) | Dental preparation | |
US10813878B2 (en) | Oral health composition | |
WO2019165338A1 (en) | Oxygenating oral and topical compositions | |
US20220378677A1 (en) | Treatment of tooth decay using a chewing gum composition comprising cannabinoids | |
KR20190041801A (en) | Composition for prevention or treatment of oral disease comprising Ginkgolide C | |
KR20180046247A (en) | Composition for prevention or treatment of oral disease comprising Verbascoside | |
KR20190041800A (en) | Composition for prevention or treatment of oral disease comprising Casticin | |
KR20180055524A (en) | Composition for prevention or treatment of oral disease comprising punicalagin | |
KR20180046248A (en) | Composition for prevention or treatment of oral disease comprising Schisandrin A | |
KR20180055520A (en) | Composition for prevention or treatment of oral disease comprising neferine | |
KR20180055523A (en) | Composition for prevention or treatment of oral disease comprising nitidine chloride | |
KR20180046251A (en) | Composition for prevention or treatment of oral disease comprising Crotonoside | |
KR20180055527A (en) | Composition for prevention or treatment of oral disease comprising eriodictyol | |
KR20180055522A (en) | Composition for prevention or treatment of oral disease comprising tiliroside | |
KR20180046246A (en) | Composition for prevention or treatment of oral disease comprising Shikonin | |
KR20180043084A (en) | Composition for prevention or treatment of oral disease comprising forsythoside B | |
KR20180055526A (en) | Composition for prevention or treatment of oral disease comprising salvianolic acid B | |
KR20180046245A (en) | Composition for prevention or treatment of oral disease comprising Nobiletin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WM. WRIGLEY JR. COMPANY, ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TIAN, MINMIN;DODDS, MICHAEL;HANLEY, BRYAN;SIGNING DATES FROM 20140113 TO 20140115;REEL/FRAME:032367/0883 |
|
AS | Assignment |
Owner name: WM. WRIGLEY JR. COMPANY, ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TIAN, MINMIN;DODDS, MICHAEL;HANLEY, BRYAN;SIGNING DATES FROM 20140113 TO 20140115;REEL/FRAME:032772/0071 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |